Abstract:Background: Autophagy is an evolutionarily conserved turnover process for intracellular substances in eukaryotes, relying on lysosomal (in animals) or vacuolar (in yeast and plants) mechanisms. In the past two decades, emerging evidence suggests that, under specific conditions, autophagy can target particular macromolecules or organelles for degradation, a process termed selective autophagy. Recently, accumulating studies have demonstrated that the abnormality of selective autophagy is closely associated with the occurrence and progression of many human diseases, including neurodegenerative diseases, cancers, metabolic diseases, and cardiovascular diseases. Aim of review: This review aims at systematically and comprehensively introducing selective autophagy and its role in various diseases, while unravelling the molecular mechanisms of selective autophagy. By providing a theoretical basis for the development of related small-molecule drugs as well as treating related human diseases, this review seeks to contribute to the understanding of selective autophagy and its therapeutic potential. Key scientific concepts of review: In this review, we systematically introduce and dissect the major categories of selective autophagy that have been discovered. We also focus on recent advances in understanding the molecular mechanisms underlying both classical and non-classical selective autophagy. Moreover, the current situation of small-molecule drugs targeting different types of selective autophagy is further summarized, providing valuable insights into the discovery of more candidate small-molecule drugs targeting selective autophagy in the future. On the other hand, we also reveal clinically relevant implementations that are potentially related to selective autophagy, such as predictive approaches and treatments tailored to individual patients.

Small molecule autophagy inducers: A new therapeutic paradigm for neural degeneration diseases

Role Of Autophagy In Neurite Degeneration In Vitro

Autophagy in Aging and Neurodegenerative Diseases: Implications for Pathogenesis and Therapy.

Induction of Autophagy in Neurite Degeneration of Mouse Superior Cervical Ganglion Neurons

Molecular targets and approaches to restore autophagy and lysosomal capacity in neurodegenerative disorders

Autophagy in Axonal and Dendritic Degeneration

Targeting selective autophagy in CNS disorders by small-molecule compounds

Small molecule regulators of autophagy identified by an image-based high-throughput screen.

Autophagy and Its Comprehensive Impact on ALS

Regulation of Autophagy in Neurodegenerative Diseases: A Brief Review on Autophagy Therapy for Neurodegenerative Diseases

Autophagy in neuritic degeneration

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

Development of small molecules for disrupting pathological amyloid aggregation in neurodegenerative diseases

Compromised autophagy and neurodegenerative diseases

Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease

Traditional Chinese medicine compounds regulate autophagy for treating neurodegenerative disease: A mechanism review

Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions

Regulation of neuronal autophagy and the implications in neurodegenerative diseases

Selective autophagy as a therapeutic target for neurological diseases

Targeting selective autophagy and beyond: From underlying mechanisms to potential therapies

The autophagy-lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson’s disease